Journal of Neural Transmission

, Volume 113, Issue 2, pp 195–203 | Cite as

Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer’s disease: comparison of a semiquantitative and a visual evaluation

  • W. Staffen
  • U. Schönauer
  • H. Zauner
  • I. Spindler
  • A. Mair
  • B. Iglseder
  • G. Bernroider
  • G. Ladurner


Due to the increasing importance of early recognition and differential diagnosis of dementias, cerebral perfusion scans using “single photon emission computed tomography” (SPECT) are increasingly integrated into the examination routine.

The goal of this study was to check the diagnostic validity of SPECT scans of MCI- and DAT-patients, two subgroups out of 369 persons with etiologically unclear cognitive dysfunction, which underwent an assessment program for probable dementia including cognitive testing, cranial computed tomography, ultrasound, routine laboratory testing including vascular risk factors.

After exclusion of patients with no or other forms of dementia we analyzed SPECT data of patients with mild cognitive impairment (MCI; n = 85) and dementia of the Alzheimer type (DAT; n = 78) in comparison with a healthy control group (n = 34).

Visual assessment as well as a manual “regions of interest” (ROI) regionalization of the cortex were performed, whereby a ROI/cerebellum ratio was calculated as a semi-quantitative value. Association cortex areas were assessed regarding frontal, temporal, and parietal lobes of both hemispheres. When comparing the ratios of patients with DAT and controls, we found a statistically significant reduction of the cerebral perfusion in all measured cortex areas (p < 0.001). The comparison of patients with MCI with the selected control group also established a statistically significant difference in the cerebral perfusion for the evaluated cortex areas with the exception of the left hemispheric frontal and parietal cortex.

A considerable number of the MCI patients showed an MMSE-score within the normal range, but with regard to the perfusion in the right hemispheric association cortex these patients also could be distinguished unambiguously from controls.

Sensitivity levels found by visual assessment were at least as high as those found by the ROI method (pathological assessment: visual 49.4% vs. ROI 47.1% for MCI; visual 75.6% vs. ROI 73.1% for DAT).

High experienced visual assessment of cerebral perfusion scans using SPECT provides an useful additional tool in diagnosis of cognitive impairment. The used semiquantitative ROI-method is nearly equivalent and does not depend on the experience of the investigator.

Keywords: Mild cognitive impairment, dementia of Alzheimer’s type, SPECT. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bartenstein, P, Grünwald, F, Kuwert, T,  et al. 2000Clinical applications of single photon emission tomography in neuromedicine.Nuklearmedizin39218232PubMedGoogle Scholar
  2. Battistin, L, Pizzolato, G, Dam, M,  et al. 1989Single photon emission tomography studies with 99 m Technetium hexamethylpropylenaminoxime in dementia: effects of acute administration of L-acetylcarnitine.Eur J Neurol29261265Google Scholar
  3. Camargo, E 2001Brain SPECT in neurology and psychiatry.J Nucl Med42611623PubMedGoogle Scholar
  4. Celsis, P 2000Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer’s disease?Ann Med32614PubMedGoogle Scholar
  5. Dahl G (1986) Reduzierter Wechsler-Intelligenztest. Hogrefe, GöttingenGoogle Scholar
  6. DeCarli, C 2001The role of neuroimaging in dementia.Clin Geriatr Med17255279CrossRefPubMedGoogle Scholar
  7. DeCarli, C, Kaye, JA, Horwitz, B, Rapoport, SI 1990Critical analysis of the use of computer assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type.Neurology40884Google Scholar
  8. Dougall NJ, Bruggink S, Ebmeier KP, et al. (2003) The clinical use of 99mTc-HMPAO in Alzheimer’s disease. In: Ebmeier KB (ed) SPECT in dementia. Karger, Basel, pp 4–37 (Adv Biol Psychiatry 22)Google Scholar
  9. Folstein, MF, Folstein, SE, McHugh, PR 1975“Mini-Mental state”. A practical method for grading the cognitive state of patients for the clinician.J Psychiatr Res12189198CrossRefPubMedGoogle Scholar
  10. Herholz, K 2003PET studies in dementia.Ann Nucl Med177989PubMedGoogle Scholar
  11. Herholz, K, Schopphoff, H, Schmidt, M,  et al. 2002Direct comparison of spatially normalized PET and SPECT scans in Alzheimer’s disease.J Nucl Med432126PubMedGoogle Scholar
  12. Hirsch, C, Bartenstein, P, Mösch, D,  et al. 1997Reduction of regional cerebral blood flow and cognitive impairment in patients with Alzheimer’s disease: evaluation of an observer-independent analytic approach.Dement Geriatr Cogn Disord898104PubMedGoogle Scholar
  13. Hoffmann, JM, Welsh-Bohmer, KA, Hanson, M,  et al. 2000FDG PET imaging in patients with pathologically verified dementia.J Nucl Med4119201928Google Scholar
  14. Jagust, WJ 2000Neuroimaging in dementia.Neurol Clin18885902CrossRefPubMedGoogle Scholar
  15. Jagust, WJ, Haan, MN, Reed, BR, Eberling, JL 1998Brain perfusion imaging predicts survival in Alzheimer’s disease.Neurology5110091013PubMedGoogle Scholar
  16. Jobst, KA, Barnetson, LB, Shepstone, BJ 1998Accurate prediction of histologically confirmed Alzheimer’s disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.Int Psychogeriatr10271302CrossRefPubMedGoogle Scholar
  17. Johnson, KA, Jones, K, Holman, BL,  et al. 1998Preclinical prediction of Alzheimer’s disease during SPECT.Neurology5015631571PubMedGoogle Scholar
  18. Kantarci, K, Jack, CR, Xu, YC,  et al. 2000Mild cognitive impairment and Alzheimer’s disease. A 1H MRS study.Neurology55210217PubMedGoogle Scholar
  19. Kemp, PM, Holmes, C, Hoffmann, SMA,  et al. 2003Alzheimer’s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia.J Neurol Neurosurg Psychiatry74715719PubMedGoogle Scholar
  20. Knopman, DS, De Kosky, ST, Cummings, JL,  et al. 2001Practice parameter: diagnosis of dementia (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology5611311132Google Scholar
  21. Kogure, D, Matsuda, H, Takashi, O,  et al. 2000Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT.J Nucl Med4111551162PubMedGoogle Scholar
  22. Lee, YC, Liu, RS, Liao, YC,  et al. 2003Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer’s disease.Eur Neurol49142145CrossRefPubMedGoogle Scholar
  23. Lehrl S, Merz J, Burkhard G, Fischer S (1991) Mehrfachwahl-Wortschatz-Intelligenztest. Straube, ErlangenGoogle Scholar
  24. Matsuda, H 2001Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease.Ann Nucl Med58592Google Scholar
  25. McKhann, G, Drachmann, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM 1984Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease.Neurology34939944PubMedGoogle Scholar
  26. Nobili, F, Brugnolo, A, Calvini, P,  et al. 2005Resting SPECT-neuropsychology correlation in very mild Alzheimer’s disease.Clin Neurophysiol116364375CrossRefPubMedGoogle Scholar
  27. Okomura, N, Shinkawa, M, Arai, H,  et al. 2000Prediction of progression in patients with mild cognitive impairment using IMP-SPECT.Nippon Ronen Igakki Zasshi37974978Google Scholar
  28. Oswald WD, Fleischmann UM (1997) Nürnberger-Alters-Inventar. Hogrefe, GöttingenGoogle Scholar
  29. Rapoport, SI, Horwitz, B, Grady, CL, Haxby, JV, DeCarli, C, Schapiro, MB 1991Abnormal brain glucose metabolism in Alzheimer’s disease as measured by positron emission tomography.Adv Exp Med Biol291231248PubMedGoogle Scholar
  30. Santens, P, Petit, H 1997Positron emission tomography in dementia.Acta Neurol Belgica97192195Google Scholar
  31. Savoiardo, M, Grisoli, M 2001Imaging dementias.Eur J Radiol11484492Google Scholar
  32. Scheltens, P, Korf, ESC 2000Contribution of neuroimaging in the diagnosis of Alzheimer’s disease and other dementias.Curr Opin Neurol13391396CrossRefPubMedGoogle Scholar
  33. Scheltens, P, Launer, LJ, Barkhof, F,  et al. 1997The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.Alzheimer Dis Assoc Disord116370PubMedGoogle Scholar
  34. Van Heertum, RL, Drocea, C, Ichise, M,  et al. 2001Single photon emission CT and positron emission tomography in the evaluation of neurologic disease.Update Nucl Med3910071033Google Scholar
  35. Van Heertum, RL, Tikofsky, RS 2003Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.Sem Nucl Med337785Google Scholar
  36. Wechsler, D 1945A standardized memory scale for clinical use.J Psychol198795Google Scholar
  37. Weiss, BD, Reed, R, Kligman, EW,  et al. 1995Litteracy and performance on the Mini-Mental State Examination.J Am Geriatr Soc43807810PubMedGoogle Scholar
  38. Wolf, H, Jelic, V, Gertz, HJ, Nordberg, A, Julin, P, Wahlund, LO 2003A critical discussion of the role of neuroimaging in mild cognitive impairment.Acta Neurol Scand [Suppl]1795276Google Scholar
  39. Yamaguchi, S, Meguro, K, Itho, M,  et al. 1997Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer’s disease as shown by MRI and PET.J Neurol Neurosurg Psychiatry62596600PubMedGoogle Scholar
  40. Zerssen D, Koeller DM (1976) Depressivitäts-Skala. Beltz, WeinheimGoogle Scholar
  41. Zung WWK (1986) Depressions-Status-Inventar (DSI). Fremdbeurteilungsskala. Beltz, WeinheimGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • W. Staffen
    • 1
  • U. Schönauer
    • 1
  • H. Zauner
    • 2
  • I. Spindler
    • 1
  • A. Mair
    • 1
  • B. Iglseder
    • 1
  • G. Bernroider
    • 3
  • G. Ladurner
    • 1
  1. 1.Department of NeurologyChristian-Doppler-Klinik, Paracelsus UniversitySalzburgAustria
  2. 2.Rehabilitation Center of the PensionsversicherungsanstaltGroßgmainAustria
  3. 3.Institute of Zoology, University of SalzburgAustria

Personalised recommendations